HGF-MET Signaling Shifts M1 Macrophages Toward an M2-Like Phenotype Through PI3K-Mediated Induction of Arginase-1 Expression

Front Immunol. 2020 Sep 2:11:2135. doi: 10.3389/fimmu.2020.02135. eCollection 2020.

Abstract

Backgrounds and Aims: Hepatocyte Growth Factor (HGF)-MET signaling is known to promote biological functions such as cell survival, cell motility, and cell proliferation. However, it is unknown if HGF-MET alters the macrophage phenotype. In this study, we aimed to study the effects of HGF-MET signaling on the M1 macrophage phenotype. Methods and Materials: Bone marrow-derived macrophages (BMDMs) isolated from mice were either polarized to an M1 phenotype by IFN-γ and LPS treatment or to an M2 phenotype by IL-4 treatment. Changes in M1 or M2 markers induced by HGF-MET signaling were evaluated. Mechanisms responsible for alternations in the macrophage phenotype and intracellular metabolism were analyzed. Results: c-Met was expressed especially in M1 macrophages polarized by treatment with IFN-γ and LPS. In M1 macrophages, HGF-MET signaling induced the expression of Arg-1 mRNA and secretion of IL-10 and TGF-β1 and downregulated the mRNA expression of iNOS, TNF-α, and IL-6. In addition, activation of the PI3K pathway and inactivation of NFκB were also observed in M1 macrophages treated with HGF. The increased Arg-1 expression and IL-10 secretion were abrogated by PI3K inhibition, whereas, no changes were observed in TNF-α and IL-6 expression. The inactivation of NFκB was found to be independent of the PI3K pathway. HGF-MET signaling shifted the M1 macrophages to an M2-like phenotype, mainly through PI3K-mediated induction of Arg-1 expression. Finally, HGF-MET signaling also shifted the M1 macrophage intracellular metabolism toward an M2 phenotype, especially with respect to fatty acid metabolism. Conclusion: Our results suggested that HGF treatment not only promotes regeneration in epithelial cells, but also leads to tissue repair by altering M1 macrophages to an M2-like phenotype.

Keywords: HGF-MET signaling; PI3K pathway; arginase-1; macrophage; phenotypic alteration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginase / biosynthesis*
  • Arginase / genetics
  • CCAAT-Enhancer-Binding Protein-beta / metabolism
  • Cell Differentiation
  • Cells, Cultured
  • Chromones / pharmacology
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Gene Expression Regulation
  • Hepatocyte Growth Factor / physiology*
  • Interferon-gamma / pharmacology
  • Lipopolysaccharides / pharmacology
  • Macrophages / classification
  • Macrophages / drug effects
  • Macrophages / enzymology
  • Macrophages / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Morpholines / pharmacology
  • Phenotype
  • Phosphatidylinositol 3-Kinases / physiology*
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • Protein Processing, Post-Translational
  • Proto-Oncogene Proteins c-met / biosynthesis
  • Proto-Oncogene Proteins c-met / genetics
  • Proto-Oncogene Proteins c-met / physiology*
  • Specific Pathogen-Free Organisms

Substances

  • CCAAT-Enhancer-Binding Protein-beta
  • Cebpb protein, mouse
  • Chromones
  • Creb1 protein, mouse
  • Cyclic AMP Response Element-Binding Protein
  • HGF protein, mouse
  • Lipopolysaccharides
  • Morpholines
  • Protein Kinase Inhibitors
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Hepatocyte Growth Factor
  • Interferon-gamma
  • Proto-Oncogene Proteins c-met
  • Arg1 protein, mouse
  • Arginase